Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this 2018 FDA Warning Letter was issued to Oeyama-Moto-Medical Group Foundation, LLC, a medical device or related healthcare company. While specific violation details are not available from the metadata provided, the letter indicates regulatory concerns significant enough to warrant formal FDA action. The issuing office and exact product category cannot be determined from the available information, limiting further characterization of the regulatory scope and nature of the violations.